• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症的表观基因组失调:寻找疾病病因和生物标志物。

Epigenomic Dysregulation in Schizophrenia: In Search of Disease Etiology and Biomarkers.

机构信息

School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.

Centre for Brain and Mental Health Research, University of Newcastle and the Hunter Medical Research Institute, Newcastle, NSW 2308, Australia.

出版信息

Cells. 2020 Aug 5;9(8):1837. doi: 10.3390/cells9081837.

DOI:10.3390/cells9081837
PMID:32764320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7463953/
Abstract

Schizophrenia is a severe psychiatric disorder with a complex array of signs and symptoms that causes very significant disability in young people. While schizophrenia has a strong genetic component, with heritability around 80%, there is also a very significant range of environmental exposures and stressors that have been implicated in disease development and neuropathology, such as maternal immune infection, obstetric complications, childhood trauma and cannabis exposure. It is postulated that epigenetic factors, as well as regulatory non-coding RNAs, mediate the effects of these environmental stressors. In this review, we explore the most well-known epigenetic marks, including DNA methylation and histone modification, along with emerging RNA mediators of epigenomic state, including miRNAs and lncRNAs, and discuss their collective potential for involvement in the pathophysiology of schizophrenia implicated through the postmortem analysis of brain tissue. Given that peripheral tissues, such as blood, saliva, and olfactory epithelium have the same genetic composition and are exposed to many of the same environmental exposures, we also examine some studies supporting the application of peripheral tissues for epigenomic biomarker discovery in schizophrenia. Finally, we provide some perspective on how these biomarkers may be utilized to capture a signature of past events that informs future treatment.

摘要

精神分裂症是一种严重的精神疾病,其症状和体征复杂多样,会导致年轻人出现严重的残疾。虽然精神分裂症有很强的遗传成分,遗传率约为 80%,但也有大量的环境暴露和压力源与疾病发展和神经病理学有关,如母体免疫感染、产科并发症、儿童期创伤和大麻暴露。据推测,表观遗传因素以及调节性非编码 RNA 介导了这些环境压力源的作用。在这篇综述中,我们探讨了最著名的表观遗传标记,包括 DNA 甲基化和组蛋白修饰,以及新兴的 RNA 介导的表观基因组状态调节剂,包括 miRNA 和 lncRNA,并讨论了它们通过脑组织的死后分析共同参与精神分裂症病理生理学的潜在作用。鉴于外周组织(如血液、唾液和嗅上皮)具有相同的遗传组成,并暴露于许多相同的环境暴露,我们还检查了一些支持应用外周组织进行精神分裂症表观基因组生物标志物发现的研究。最后,我们提供了一些关于这些生物标志物如何被用来捕捉过去事件的特征,为未来的治疗提供信息的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/7463953/abebbf79d677/cells-09-01837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/7463953/46c1965a2ab9/cells-09-01837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/7463953/abebbf79d677/cells-09-01837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/7463953/46c1965a2ab9/cells-09-01837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/7463953/abebbf79d677/cells-09-01837-g002.jpg

相似文献

1
Epigenomic Dysregulation in Schizophrenia: In Search of Disease Etiology and Biomarkers.精神分裂症的表观基因组失调:寻找疾病病因和生物标志物。
Cells. 2020 Aug 5;9(8):1837. doi: 10.3390/cells9081837.
2
Epigenetics of Schizophrenia.精神分裂症的表观遗传学。
Psychiatry Res. 2021 Nov;305:114218. doi: 10.1016/j.psychres.2021.114218. Epub 2021 Sep 22.
3
Role of Epigenomics in Bone and Cartilage Disease.表观基因组学在骨与软骨疾病中的作用。
J Bone Miner Res. 2019 Feb;34(2):215-230. doi: 10.1002/jbmr.3662. Epub 2019 Feb 4.
4
Characterization of cross-tissue genetic-epigenetic effects and their patterns in schizophrenia.精神分裂症跨组织遗传-表观遗传效应的特征及其模式。
Genome Med. 2018 Feb 26;10(1):13. doi: 10.1186/s13073-018-0519-4.
5
Epigenetic mechanisms in schizophrenia.精神分裂症中的表观遗传机制。
Prog Biophys Mol Biol. 2015 Jul;118(1-2):1-7. doi: 10.1016/j.pbiomolbio.2015.04.008. Epub 2015 May 7.
6
Review: Regulation of the cancer epigenome by long non-coding RNAs.综述:长非编码 RNA 对癌症表观基因组的调控。
Cancer Lett. 2017 Oct 28;407:106-112. doi: 10.1016/j.canlet.2017.03.040. Epub 2017 Apr 9.
7
Uncovering epigenetic landscape: a new path for biomarkers identification and drug development.揭示表观遗传学景观:生物标志物鉴定和药物开发的新途径。
Mol Biol Rep. 2020 Nov;47(11):9097-9122. doi: 10.1007/s11033-020-05916-3. Epub 2020 Oct 21.
8
[Epigenetics of schizophrenia: a review].[精神分裂症的表观遗传学:综述]
Encephale. 2014 Oct;40(5):380-6. doi: 10.1016/j.encep.2014.06.005. Epub 2014 Aug 12.
9
Epigenetic mechanisms in schizophrenia.精神分裂症中的表观遗传机制。
Dialogues Clin Neurosci. 2014 Sep;16(3):405-17. doi: 10.31887/DCNS.2014.16.3/sakbarian.
10
Use of the epigenetic toolbox
to contextualize common variants associated with schizophrenia risk
.利用表观遗传工具集来阐释与精神分裂症风险相关的常见变异。
Dialogues Clin Neurosci. 2019 Dec;21(4):407-416. doi: 10.31887/DCNS.2019.21.4/sakbarian.

引用本文的文献

1
Biomarkers in schizophrenia - past, present and future.精神分裂症中的生物标志物——过去、现在与未来
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):69-79. doi: 10.47162/RJME.66.1.06.
2
Dysregulation of MiRNAs in schizophrenia in an Egyptian patient population.埃及患者群体中精神分裂症患者体内微小RNA的失调
Sci Rep. 2025 May 16;15(1):16998. doi: 10.1038/s41598-025-01831-4.
3
Epigenetics factors in schizophrenia: future directions for etiologic and therapeutic study approaches.精神分裂症中的表观遗传学因素:病因学和治疗研究方法的未来方向

本文引用的文献

1
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders.针对主要精神障碍的 162 种外周生物标志物的循证伞式综述。
Transl Psychiatry. 2020 May 18;10(1):152. doi: 10.1038/s41398-020-0835-5.
2
Epigenetic Modifications in Schizophrenia and Related Disorders: Molecular Scars of Environmental Exposures and Source of Phenotypic Variability.精神分裂症及相关障碍中的表观遗传学修饰:环境暴露的分子痕迹和表型变异性的来源。
Biol Psychiatry. 2021 Feb 1;89(3):215-226. doi: 10.1016/j.biopsych.2020.03.008. Epub 2020 Mar 28.
3
Derivation of poly-methylomic profile scores for schizophrenia.
Ann Gen Psychiatry. 2025 Apr 4;24(1):21. doi: 10.1186/s12991-025-00557-x.
4
G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials.G9a:神经退行性疾病的一种表观遗传治疗策略——从靶点发现到临床试验
Med Res Rev. 2025 May;45(3):985-1015. doi: 10.1002/med.22096. Epub 2025 Jan 6.
5
Very Early-Onset Schizophrenia with Accompanying Obsessive-Compulsive Symptoms: A Case Report of a Female with 16p13.11 Duplication.极早发性精神分裂症伴强迫症状:一例16p13.11重复女性病例报告
Psychiatry Clin Psychopharmacol. 2024 Nov 28;34(4):356-360. doi: 10.5152/pcp.2024.24949.
6
The Association and Prognostic Implications of Long Non-Coding RNAs in Major Psychiatric Disorders, Alzheimer's Diseases and Parkinson's Diseases: A Systematic Review.长链非编码 RNA 在重大精神疾病、阿尔茨海默病和帕金森病中的关联和预后意义:系统评价。
Int J Mol Sci. 2024 Oct 12;25(20):10995. doi: 10.3390/ijms252010995.
7
Autism spectrum disorder: difficulties in diagnosis and microRNA biomarkers.自闭症谱系障碍:诊断困难与微小RNA生物标志物
Neural Regen Res. 2025 Oct 1;20(10):2776-2786. doi: 10.4103/NRR.NRR-D-24-00712. Epub 2024 Sep 24.
8
A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning.通过自动化机器学习,在首发精神分裂症患者中发现一种新型基于血液的表观遗传生物标志物。
Transl Psychiatry. 2024 Jun 17;14(1):257. doi: 10.1038/s41398-024-02946-4.
9
The Correlation Between Peripheral Blood Micro-Ribonucleic Acid Expression Level and Personality Disorder in Patients with Schizophrenia.精神分裂症患者外周血微小核糖核酸表达水平与人格障碍的相关性
Alpha Psychiatry. 2024 Jan 1;25(1):23-29. doi: 10.5152/alphapsychiatry.2024.231216. eCollection 2024 Jan.
10
microRNA and the Post-Transcriptional Response to Oxidative Stress during Neuronal Differentiation: Implications for Neurodevelopmental and Psychiatric Disorders.微小RNA与神经元分化过程中对氧化应激的转录后反应:对神经发育和精神疾病的影响
Life (Basel). 2024 Apr 26;14(5):562. doi: 10.3390/life14050562.
用于精神分裂症的多甲基组学特征评分的推导。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109925. doi: 10.1016/j.pnpbp.2020.109925. Epub 2020 Mar 16.
4
Schizophrenia-associated MicroRNA-Gene Interactions in the Dorsolateral Prefrontal Cortex.精神分裂症相关的 microRNA-基因在背外侧前额叶皮层的相互作用。
Genomics Proteomics Bioinformatics. 2019 Dec;17(6):623-634. doi: 10.1016/j.gpb.2019.10.003. Epub 2020 Feb 14.
5
Global DNA hypomethylation and its correlation to the betaine level in peripheral blood of patients with schizophrenia.精神分裂症患者外周血中海马 DNA 低甲基化及其与甜菜碱水平的相关性。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Apr 20;99:109855. doi: 10.1016/j.pnpbp.2019.109855. Epub 2020 Jan 3.
6
Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings.精神分裂症和其他精神病障碍中的表观遗传机制:对经验性人类研究结果的系统综述。
Mol Psychiatry. 2020 Aug;25(8):1718-1748. doi: 10.1038/s41380-019-0601-3. Epub 2020 Jan 6.
7
Altered expression of microRNA-223 in the plasma of patients with first-episode schizophrenia and its possible relation to neuronal migration-related genes.首发精神分裂症患者血浆中 microRNA-223 的表达改变及其与神经元迁移相关基因的可能关系。
Transl Psychiatry. 2019 Nov 11;9(1):289. doi: 10.1038/s41398-019-0609-0.
8
Identification of Biomarkers in Neuropsychiatric Disorders Based on Systems Biology and Epigenetics.基于系统生物学和表观遗传学的神经精神疾病生物标志物鉴定
Front Genet. 2019 Oct 11;10:985. doi: 10.3389/fgene.2019.00985. eCollection 2019.
9
Purification and Identification of miRNA Target Sites in Genome Using DNA Affinity Precipitation.利用DNA亲和沉淀法纯化和鉴定基因组中的miRNA靶位点
Front Genet. 2019 Sep 12;10:778. doi: 10.3389/fgene.2019.00778. eCollection 2019.
10
Pan-cancer analysis on microRNA-associated gene activation.泛癌症分析中 miRNA 相关基因激活。
EBioMedicine. 2019 May;43:82-97. doi: 10.1016/j.ebiom.2019.03.082. Epub 2019 Apr 5.